Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review

Introduction According to CDC’s Autism and Developmental Disabilities Monitoring Network surveillance in 2016, autism spectrum disorder (ASD) was prevalent in 1 in 54 children in 11 states of the US. Objectives This systematic review provides an overview of Umbilical Cord Blood Infusion (UCB) to...

Full description

Bibliographic Details
Main Authors: M. Adnan, F. Motiwala, Z. Mansuri, A. Reddy
Format: Article
Language:English
Published: Cambridge University Press 2021-04-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S0924933821011093/type/journal_article
_version_ 1797616644141350912
author M. Adnan
F. Motiwala
Z. Mansuri
A. Reddy
author_facet M. Adnan
F. Motiwala
Z. Mansuri
A. Reddy
author_sort M. Adnan
collection DOAJ
description Introduction According to CDC’s Autism and Developmental Disabilities Monitoring Network surveillance in 2016, autism spectrum disorder (ASD) was prevalent in 1 in 54 children in 11 states of the US. Objectives This systematic review provides an overview of Umbilical Cord Blood Infusion (UCB) to decrease symptoms severity in children with (ASD). Methods Systematic literature search was conducted using “Autism” OR “Autism spectrum disorder” AND “Autologous Umbilical Cord Blood Infusion (AUCBI)” OR “umbilical cord blood” OR “Allogeneic Cord Blood” in PubMed, Embase, and PsycINFO. Three studies were qualified on AUCBI. Results We found 3 studies on UCBI The UCB Infusion phase-I/ open-label trial showed significant improvement in cognitive and behavior scales, especially in the social domain in the first six months, and was more significant in children with higher baseline nonverbal intelligence quotients. Other study/phase II trial failed to show any effects of UCBI on social communication, vocabulary, and other autism symptoms. On subgroup analysis, the improvement in Clinical Global Impression - Improvement (CGI-I) in children without intellectual disability (ID) with the allogenic (not autologous) UCBI was observed. Another randomized, blinded crossover trial failed to show any difference between improvements in CGI baseline severity scores in placebo vs. cord blood infusion groups. Conclusions The data provides evidence to support the efficacy and safety of autologous UCBI in symptom severity reductions and improved clinical outcomes without intellectual disability. However, the evidence is inadequate and future large scale clinical are required.
first_indexed 2024-03-11T07:44:10Z
format Article
id doaj.art-620bd69ad70444e69d6c00b674dd5f46
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:44:10Z
publishDate 2021-04-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-620bd69ad70444e69d6c00b674dd5f462023-11-17T05:07:54ZengCambridge University PressEuropean Psychiatry0924-93381778-35852021-04-0164S415S41510.1192/j.eurpsy.2021.1109Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative reviewM. Adnan0F. Motiwala1Z. Mansuri2A. Reddy3Psychiatry, Mercy Hospital and Medical Center, Lincolnwood, United States of AmericaPsychiatry, Texas Tech University Health Sciences Center at the Permian Basin, Midland, United States of AmericaDepartment Of Psychiatry, Boston Children’s Hospital/Harvard Medical School, Boston, United States of AmericaPsychiatry, Virginia Tech Carilion School of Medicine, Roanoke, United States of America Introduction According to CDC’s Autism and Developmental Disabilities Monitoring Network surveillance in 2016, autism spectrum disorder (ASD) was prevalent in 1 in 54 children in 11 states of the US. Objectives This systematic review provides an overview of Umbilical Cord Blood Infusion (UCB) to decrease symptoms severity in children with (ASD). Methods Systematic literature search was conducted using “Autism” OR “Autism spectrum disorder” AND “Autologous Umbilical Cord Blood Infusion (AUCBI)” OR “umbilical cord blood” OR “Allogeneic Cord Blood” in PubMed, Embase, and PsycINFO. Three studies were qualified on AUCBI. Results We found 3 studies on UCBI The UCB Infusion phase-I/ open-label trial showed significant improvement in cognitive and behavior scales, especially in the social domain in the first six months, and was more significant in children with higher baseline nonverbal intelligence quotients. Other study/phase II trial failed to show any effects of UCBI on social communication, vocabulary, and other autism symptoms. On subgroup analysis, the improvement in Clinical Global Impression - Improvement (CGI-I) in children without intellectual disability (ID) with the allogenic (not autologous) UCBI was observed. Another randomized, blinded crossover trial failed to show any difference between improvements in CGI baseline severity scores in placebo vs. cord blood infusion groups. Conclusions The data provides evidence to support the efficacy and safety of autologous UCBI in symptom severity reductions and improved clinical outcomes without intellectual disability. However, the evidence is inadequate and future large scale clinical are required. https://www.cambridge.org/core/product/identifier/S0924933821011093/type/journal_articleautism spectrum disorder
spellingShingle M. Adnan
F. Motiwala
Z. Mansuri
A. Reddy
Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
European Psychiatry
autism spectrum disorder
title Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
title_full Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
title_fullStr Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
title_full_unstemmed Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
title_short Human umbilical cord blood infusions in management of autism spectrum disorder: Narrative review
title_sort human umbilical cord blood infusions in management of autism spectrum disorder narrative review
topic autism spectrum disorder
url https://www.cambridge.org/core/product/identifier/S0924933821011093/type/journal_article
work_keys_str_mv AT madnan humanumbilicalcordbloodinfusionsinmanagementofautismspectrumdisordernarrativereview
AT fmotiwala humanumbilicalcordbloodinfusionsinmanagementofautismspectrumdisordernarrativereview
AT zmansuri humanumbilicalcordbloodinfusionsinmanagementofautismspectrumdisordernarrativereview
AT areddy humanumbilicalcordbloodinfusionsinmanagementofautismspectrumdisordernarrativereview